Chin Surgery (Mentoplasty / Genioplasty): Procedure, Risks & Recovery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Chin surgery — medically termed mentoplasty or genioplasty — is a surgical procedure that reshapes, repositions, or augments the chin to create better facial balance and proportion. The chin plays a central role in defining the lower third of the face, and even minor discrepancies can significantly affect the perceived harmony of facial features. Surgeons perform chin procedures to address a receding chin (microgenia), an overly prominent chin (macrogenia), asymmetry, or chin deformities resulting from trauma or congenital conditions.

There are two broad categories: alloplastic augmentation, in which a solid silicone or porous polyethylene implant is placed over the existing bone to increase projection or width; and osseous genioplasty, in which the surgeon cuts the chin bone (osteotomy), repositions it in three-dimensional space, and fixes it with titanium plates and screws. Osseous genioplasty offers greater versatility — the bone can be moved forward, backward, up, down, or rotated — making it the preferred technique when significant skeletal correction is needed or when the chin deficit accompanies jaw malocclusion.

Chin surgery is frequently combined with rhinoplasty (nose reshaping) or neck liposuction to maximise facial harmony in a single anaesthetic episode. According to the American Society of Plastic Surgeons, chin augmentation has ranked among the fastest-growing cosmetic procedures globally, reflecting growing recognition that facial aesthetics depend on the balance among nose, chin, and neck rather than any single feature in isolation. Internationally, cost savings of 50–70 % make India, Thailand, and Turkey popular medical tourism destinations for this procedure.

Chin surgery addresses a spectrum of structural and aesthetic concerns of the lower face:

• Microgenia (weak or receding chin): The most common indication; the chin lacks forward projection relative to the nose and forehead, creating an imbalanced profile.
• Macrogenia (prominent chin): Excessive chin projection or vertical height that dominates the lower face; corrected by reducing or setting back the bone.
• Chin asymmetry: Lateral deviation or height discrepancy between the two sides of the chin, often related to underlying skeletal asymmetry.
• Traumatic chin deformity: Post-fracture malunion or soft-tissue defects following facial injuries.
• Congenital chin hypoplasia: Under-development of the mandibular symphysis as part of conditions such as hemifacial microsomia or Pierre Robin sequence.
• Double chin with skeletal deficiency: When submental fat coexists with a short chin, augmentation combined with liposuction produces superior cosmetic results compared to liposuction alone.
• Obstructive sleep apnoea (adjunct): Rarely, advancement genioplasty is performed as part of maxillomandibular advancement to enlarge the upper airway.

Ideal candidates for chin surgery share several characteristics that predict safe surgery and satisfying outcomes:

• Skeletal maturity: Facial bones must have finished growing — typically age 17–18 in females and 18–21 in males. Operating before growth completion risks reoperation as the residual bone continues to develop.
• Good general health: Absence of uncontrolled diabetes, coagulopathy, or active infection. Smokers are counselled to quit at least 4–6 weeks before surgery, as nicotine impairs wound healing and implant integration.
• Realistic expectations: Patients who understand that surgery improves balance rather than creating a new identity, and who have stable psychological well-being, achieve the highest satisfaction rates.
• Specific structural deficit: Clinical examination and cephalometric analysis (lateral skull X-ray measurements) confirm a true skeletal discrepancy rather than a soft-tissue illusion. For implants, the ideal candidate has mild-to-moderate chin deficiency with a well-aligned dental bite (Class I occlusion).
• No active orthodontic correction needed: When significant bite problems coexist, orthognathic jaw surgery (Le Fort I + BSSO) is planned first, and genioplasty may be incorporated into the same operative plan.

Patients with autoimmune disorders, prior chin radiation, or active psychiatric illness warrant specialist evaluation before proceeding.

The choice of technique is guided by the degree and direction of chin discrepancy, dental occlusion, surgeon preference, and patient expectations.

1. Silicone Chin Implant (Alloplastic Augmentation)

A solid silicone implant is inserted through a small incision hidden either inside the lower lip (intraoral) or in the natural crease beneath the chin (submental). The implant is placed directly on the chin bone beneath the periosteum (bone membrane), providing increased projection. Silicone implants come in multiple shapes — central, extended, anatomical — to address width, height, or projection deficits. Operating time is approximately 45–90 minutes under local anaesthesia with sedation or general anaesthesia. Implants are FDA-approved and carry a low infection rate (<2 %) when placed by experienced surgeons.

2. Porous Polyethylene Implant (Medpor)

An alternative implant material with an open-pore structure that allows soft tissue and vascular in-growth, theoretically reducing migration and infection risk. It is firmer than silicone and more difficult to remove if revision is needed.

3. Osseous Genioplasty (Sliding Genioplasty)

Performed under general anaesthesia through an intraoral incision, the surgeon makes a horizontal osteotomy (bone cut) below the mental nerve roots and advances, sets back, vertically shortens, or lengthens the mobilised chin segment before securing it with titanium mini-plates. This technique is uniquely capable of correcting asymmetry and vertical excess that implants cannot address. It is preferred when the chin deficit is moderate-to-severe (>8–10 mm), when vertical reduction is needed, or when correcting asymmetry.

4. Injectable Filler Augmentation (Non-surgical)

Hyaluronic acid or calcium hydroxyapatite fillers can temporarily augment a mildly receding chin without surgery. Results last 12–18 months. This is appropriate for patients seeking a preview of augmentation before committing to surgery, or those unsuitable for general anaesthesia.

5. Liposuction + Chin Augmentation (Combined)

Submental liposuction removes excess fat under the chin simultaneously, improving neck definition and maximising the augmentation result through a single procedure.

When performed by an experienced craniofacial or plastic surgeon, chin surgery delivers measurable functional and aesthetic improvements:

• Improved facial proportion: Augmentation corrects the visual imbalance between nose and chin, often making the nose appear smaller without rhinoplasty.
• Enhanced profile definition: A well-projected chin sharpens the cervicomental angle, producing a more defined jaw-neck contour.
• Long-lasting results: Silicone implants may last decades with minimal maintenance; osseous genioplasty results are permanent as the repositioned bone heals in its new position.
• High patient satisfaction: Studies report satisfaction rates of 85–95 % for appropriately selected candidates (Gui et al., Plastic and Reconstructive Surgery, 2018).
• Minimal visible scarring: Intraoral incisions leave no external scars; submental incisions heal in a natural skin crease and are barely visible.
• Quick recovery: Most patients return to office work within 7–10 days; social activities resume in 2–3 weeks as bruising and swelling subside.
• Psychological benefit: Improved body image and self-confidence are consistently reported in validated quality-of-life instruments such as the FACE-Q questionnaire.

Chin surgery is generally safe, but all surgical procedures carry inherent risks. Patients should discuss these thoroughly with their surgeon before providing informed consent.

Implant-Specific Risks

• Implant displacement or migration: Occurs in 2–5 % of cases, particularly if the implant is not securely positioned. Revision surgery may be required.
• Bone resorption: Chronic pressure from a silicone implant can cause gradual thinning of the underlying chin bone in a small percentage of long-term cases.
• Implant infection: Infection rates are low (1–3 %) but require implant removal, antibiotic therapy, and delayed replacement if it occurs.
• Implant extrusion: Rare; occurs when infection or poor tissue coverage causes the implant to erode through the skin or mucosa.

General Surgical Risks

• Nerve injury: The mental nerve (provides sensation to the lower lip and chin) runs adjacent to the operative field. Temporary numbness affects up to 30 % of patients and resolves within weeks to months; permanent sensory loss is rare (<1 %).
• Haematoma and seroma: Blood or fluid accumulation beneath the skin may require aspiration or drainage.
• Asymmetry: Minor asymmetry is common; significant asymmetry requiring revision occurs in approximately 3–5 % of cases.
• Anaesthesia risks: Standard risks of general or sedation anaesthesia, including allergic reaction and cardiovascular events, are minimised with pre-operative screening.
• Unsatisfactory aesthetic result: Personal preferences differ, and a small proportion of patients seek revision for size, shape, or position adjustments.

Seek immediate medical attention if you develop fever, increasing pain, redness, or discharge from the incision site — these may signal infection requiring urgent treatment.

Recovery from chin surgery is generally well-tolerated and follows a predictable timeline:

Immediate Post-Operative Period (Days 1–7)

Patients wake from anaesthesia with a firm chin dressing or tape in place. Swelling, bruising, and tightness around the chin and lower lip are expected and peak at 48–72 hours. A liquid or soft-food diet is maintained for the first 5–7 days to minimise jaw movement. Oral antibiotics and analgesics are prescribed; chlorhexidine mouthwash is used after intraoral procedures.

Early Recovery (Weeks 2–4)

Most visible bruising fades by the end of the second week. External sutures (if used) are removed at 5–7 days; intraoral sutures dissolve within 2–3 weeks. Patients can return to desk work and light activities in 7–10 days. Strenuous exercise, contact sports, and activities risking a blow to the face are restricted for 4–6 weeks. Direct sun exposure should be avoided to prevent hyperpigmentation of the healing submental scar.

Long-Term Follow-Up (1–6 Months)

Final aesthetic results become apparent once oedema fully resolves, typically at 3–6 months. For osseous genioplasty, a follow-up panoramic X-ray or CT scan at 3 months confirms bone healing and plate position. Implant patients require no routine imaging unless symptoms develop. Annual check-ins with the plastic or maxillofacial surgeon are recommended for the first 2–3 years to monitor for late complications such as bone resorption or implant shift.

Patients travelling internationally for chin surgery should plan a minimum stay of 7–10 days to allow for wound checks before flying home, and should inform their local GP of the procedure details upon return.

The total cost of chin surgery varies considerably based on technique, destination country, surgeon experience, and facility type:

• Surgical technique: Osseous genioplasty (with general anaesthesia and titanium hardware) costs more than simple implant placement under local sedation.
• Implant material: Medpor implants cost more than standard silicone; custom computer-designed implants (milled from patient's CT data) add significant expense.
• Surgeon credentials: Fellowship-trained plastic surgeons and craniofacial specialists command higher fees, but lower complication and revision rates typically offset the premium.
• Facility fees: Private hospital operating theatre costs, anaesthesiologist fees, and post-operative nursing care.
• Country of treatment: Typical cost ranges are USD 3,000–8,000 in the United States; USD 2,500–6,000 in the United Kingdom; USD 1,500–4,000 in Thailand and Malaysia; and USD 800–2,500 in India — representing savings of 60–75 % compared to Western prices for comparable quality at accredited centres.
• Combined procedures: Chin surgery performed simultaneously with rhinoplasty or liposuction shares anaesthesia and theatre costs, reducing the per-procedure expense.
• Travel and accommodation: International patients should budget for flights, accommodation (7–14 nights), local transport, and a contingency fund for any unplanned follow-up visits.

Use MyMedicPlus to compare verified hospital prices across destinations and request personalised quotes from JCI-accredited facilities.

Not every patient with chin concerns requires surgery. Several alternatives exist, each with distinct advantages and limitations:

• Hyaluronic acid filler: Injected in-office in 15–30 minutes; provides 12–18 months of subtle augmentation with no downtime. Ideal for trial augmentation or mild cases.
• Calcium hydroxyapatite filler (Radiesse): Longer-lasting than HA (18–24 months) and stimulates collagen; provides more projection than HA but is not reversible.
• Botulinum toxin (Botox): Relaxes the mentalis muscle, softening chin dimpling (peau d'orange texture) without adding projection. Not appropriate for structural deficiency.
• Orthognathic jaw surgery: When chin deficiency accompanies dental malocclusion (under- or overbite), combined maxillary and mandibular jaw surgery corrects both function and aesthetics more comprehensively than chin surgery alone.
• Orthodontic treatment: In adolescents, functional appliances can influence jaw growth to improve chin projection before skeletal maturity — a non-surgical option unavailable to adults.
• Weight management and exercise: For patients whose main concern is submental fat rather than skeletal deficiency, diet, exercise, or minimally invasive fat reduction (CoolSculpting, Kybella injections) may suffice.